Amsterdam, the Netherlands – 22 February 2019 — Esperite N.V. (Euronext: ESP) and Polski Bank Komórek Macierzystych S.A. (WSE: PBKM) are pleased to announce that they have entered into an Memorandum of Understanding (MoU) regarding the potential acquisition by PBKM of substantially all Cryo-Save’s business related to stem cell banking (the Proposed Acquisition). The Proposed Acquisition leverages the respective strengths and quality standards of the two publicly traded companies that are both leading in the stem cell banking sector. Cryo-Save is one of the largest and longest operating stem cell bank in Europe, in which store more than 330.000 umbilical cord blood samples and tissues. [Read more…]
Mogrify Raises $3.7M for Direct Cell Reprogramming and Appoints Dr. Disley CEO
Mogrify (Cell Mogrify Ltd) is a private biotechnology company has developed a direct cellular conversion technology to allow for the transformation (transmogrification) of any mature human cell type into any other – without going through a pluripotent stem cell- or progenitor cell-state. [Read more…]
Gilead Gets Notice of Compliance for Yescarta™ from Health Canada
Yescarta™ is positioned to join Kymriah™ as the second chimeric antigen receptor T cell (CAR-T) therapy to achieve regulatory approval in Canada, based on exciting news released this month from Gilead Sciences Canada. [Read more…]
Americord announces five-compartment bags and best-in-industry quality guarantee
New York, NY; February 19, 2019 — Americord Registry announced today that it will begin offering five-compartment freezing bags for all new customers storing cord blood as well as the highest quality guarantee in the industry. While industry-standard freezing bags typically contain two compartments, one holding eighty percent of the cord blood and a second holding twenty percent, Americord’s new freezing bags contain five compartments with twenty percent of the cord blood in each compartment. [Read more…]
Webinar Case Study: ‘Companion Informatics’ to Automate Immunotherapy Manufacturing and Treatment
L7 Informatics is honored to host a Free Webinar exploring a Case Study related to “‘Companion Informatics’ to Automate Immunotherapy Manufacturing and Treatment.”
Webinar: Companion Informatics’ to Automate Immunotherapy Manufacturing & Treatment
Genomics-driven precision medicine and regenerative medicine including cell and gene therapies require a new category of “companion informatics” software that automates and synchronizes complex data and process management. This software is applicable throughout the life-cycle of these complex therapeutics as they make their way from bench to clinical trials to bedside. [Read more…]
- « Previous Page
- 1
- …
- 215
- 216
- 217
- 218
- 219
- …
- 338
- Next Page »